07/23/2025
8:58 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form S-8 POS | |
07/23/2025
8:58 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
07/23/2025
8:58 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form POS AM | |
07/23/2025
8:58 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form S-4
Registration statement under Securities Act of 1933 | |
07/16/2025
8:00 AM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/16/2025
8:01 AM | Cyclacel Pharmaceuticals (Subject)
Cyclacel Pharmaceuticals, Inc. (Subject)
| Form 425 | |
07/07/2025
4:44 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form DEF 14C | |
07/07/2025
5:04 AM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/07/2025
5:08 AM | Cyclacel Pharmaceuticals (Subject)
Cyclacel Pharmaceuticals, Inc. (Subject)
| Form 425 | |
07/02/2025
8:00 AM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2025
4:22 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form DEFA14A | |
Get the Latest News and Ratings for CYCC and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Cyclacel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
06/25/2025
12:31 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form PRE 14C | |
05/30/2025
8:56 PM | Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
Ho Jien Shiung (Reporting)
| Form 3/A | |
05/30/2025
8:57 PM | Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
Ho Kee Wee (Reporting)
| Form 3/A | |
05/30/2025
8:58 PM | Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
SURIA SUKSES ENGINEERING SDN BHD (Reporting)
| Form 3/A | |
05/30/2025
8:58 PM | Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
Tan Kok Hui (Reporting)
| Form 3/A | |
05/23/2025
4:03 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form DEF 14C | |
05/15/2025
2:24 PM | ARMISTICE CAPITAL, LLC (Filed by)
Cyclacel Pharmaceuticals (Subject)
Cyclacel Pharmaceuticals, Inc. (Subject)
| Form SCHEDULE 13G/A | |
05/15/2025
1:39 PM | Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
Ho Jien Shiung (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/14/2025
2:30 PM | Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
Tan Kok Hui (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/14/2025
7:50 AM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form PRE 14C | |
05/07/2025
10:00 AM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2025
11:15 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form EFFECT | |
04/25/2025
1:38 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
04/24/2025
2:09 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form DEF 14A | |
04/21/2025
5:08 AM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/17/2025
4:00 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
04/02/2025
3:42 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/31/2025
2:31 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form NT 10-K | |
03/25/2025
1:19 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form D
Notice of Exempt Offering of Securities | |
03/24/2025
10:03 AM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/24/2025
5:01 AM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form PRE 14C | |
03/14/2025
5:00 AM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2025
9:32 AM | Cyclacel Pharmaceuticals (Subject)
Cyclacel Pharmaceuticals, Inc. (Subject)
Doris Wong Sing Ee (Filed by)
| Form SCHEDULE 13D | |
02/28/2025
3:46 PM | Cyclacel Pharmaceuticals (Subject)
Cyclacel Pharmaceuticals, Inc. (Subject)
Lazar David E. (Filed by)
| Form SCHEDULE 13D | |
02/28/2025
3:47 PM | Ben-Tzvi Avraham (Reporting)
Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
3:48 PM | Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
Lazar David E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
3:48 PM | Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
NATAN DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
10:31 AM | Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
Kiu Cu Seng (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/28/2025
10:31 AM | Chong Kwang Fock (Reporting)
Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/28/2025
10:32 AM | Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
Doris Wong Sing Ee (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off (Ad) Right now, we’re witnessing a monumental shift in the world. Our No. 1 AI Pick is currently trading for pennies on the dollar compared to Nividia. |
02/24/2025
7:31 AM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
4:40 PM | ARMISTICE CAPITAL, LLC (Filed by)
Cyclacel Pharmaceuticals (Subject)
Cyclacel Pharmaceuticals, Inc. (Subject)
| Form SCHEDULE 13G/A | |
02/10/2025
4:45 PM | Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
Lazar David E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
3:46 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/05/2025
3:40 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/21/2025
5:02 AM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form DEF 14A | |
01/10/2025
3:46 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form PRER14A | |
01/10/2025
5:04 AM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2025
4:25 PM | Ben-Tzvi Avraham (Reporting)
Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/08/2025
5:30 AM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form PRE 14A | |
01/07/2025
6:04 PM | Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
Lazar David E. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/07/2025
6:06 PM | Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
NATAN DAVID (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/07/2025
6:07 PM | Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
NATAN DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
7:17 AM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2024
3:15 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/26/2024
5:38 AM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form D
Notice of Exempt Offering of Securities | |
11/15/2024
5:05 AM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
6:21 PM | Cyclacel Pharmaceuticals (Subject)
Cyclacel Pharmaceuticals, Inc. (Subject)
Lind Global Fund II LP (Filed by)
| Form SC 13G/A | |
11/12/2024
4:10 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/12/2024
4:00 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2024
8:00 AM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form RW | |
10/24/2024
3:00 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2024
5:00 AM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
08/30/2024
8:08 AM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/22/2024
3:15 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/31/2024
3:00 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
